NCT00418756View on ClinicalTrials.gov

Effects of Rifampin on the Pharmacokinetics of Nilotinib in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

November 30, 2006

Conditions
Healthy
Interventions
DRUG

Nilotinib

Semi-synthetic antibiotic derivative of rifamycin B and is known to induce cytochrome P-450 (CYP) enzymes.

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY